PTGX Protagonist Therapeutics Inc

held by 1 manager in Q2 2026

Manager	% of their portfolio	Held	Activity	Value	Shares
Stanley Druckenmiller Duquesne Family Office	0.59%	1.0 yr	Add 30.8%	$26M	208,900

Search